A
Akari Therapeutics, Plc (AKTX)
NCM – Real Time Price. Currency in USD
3.06
-2.09 (-40.58%)
At close: May 12, 2026, 4:00 PM EDT
3.12
+0.06 (1.96%)
After-hours: May 12, 2026, 7:53 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.06
-2.09 (-40.58%)
At close: May 12, 2026, 4:00 PM EDT
3.12
+0.06 (1.96%)
After-hours: May 12, 2026, 7:53 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $5.3M significantly exceed its total debt $754.0K, ensuring strong financial flexibility
Total current liabilities $12.4M surpass Total current assets $5.5M, signaling liquidity issues
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-4.5x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.44 | 6.05 | 4.0 | |
| Quick ratio | 0.44 | 5.63 | 4.0 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | -4.46 | -16.91 | 1.0 | |
| Weighted average score | 5.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -4K | -4K | -14K | N/A | N/A |
| Operating Income | -25M | -17M | -17M | -12M | -12M |
| Net Income | -18M | -10M | -20M | -17M | -17M |
| EBITDA | -25M | -17M | -17M | -12M | -12M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 75.37 | 5.5 |
| Next quarter | N/A | 42.08 | 5.5 |
| Current year | N/A | 72.1 | 5.5 |
| Next year | N/A | 18.89 | 5.0 |
| Weighted average score | 5.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 16.82 | 25.25 | -44.57 | 7.5 |
| Y/Y | 999 | -41.56 | 56.03 | -43.05 | 5.5 |
| 3y average | 999 | -13.75 | 687.11 | 20.92 | 7.8 |
| 5y average | 999 | -8.84 | 632.07 | 7.68 | 6.8 |
| Weighted average score | 6.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |